Products for Research Use Only
RegisterLogin

Intetumumab

CAT: 0804-HY-P99296-01Size: 1 mgDry Ice: YesHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-P99296-01Size:1 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Intetumumab (CNTO 95) is a humanized monoclonal antibody targeting CD51/αV-integrins. Intetumumab is used in the research of pancreatic ductal adenocarcinoma (PDAC) [1].
CAS Number
725735-28-4
Product Name Alternative
CNTO 95; Anti-Human CD51 Recombinant Antibody
UNSPSC
12352203
Target
Integrin
Type
Inhibitory Antibodies
Related Pathways
Cytoskeleton
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/intetumumab.html
Purity
99.24
Solubility
10 mM in DMSO
Smiles
[Intetumumab]
Molecular Weight
(145.14 kDa)
References & Citations
[1]Bellone M, et, al. Expression of αV-integrins in uterine serous papillary carcinomas; implications for targeted therapy with intetumumab (CNTO 95), a fully human antagonist anti-αV-integrin antibody. Int J Gynecol Cancer. 2011 Aug;21 (6) :1084-90.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 2

Alternative Products

CatalogName
T76812-01Intetumumab
GTR18337970-01Intetumumab Antibody
591930Intetumumab (ITGAV_ITGB3)
MBS1563430-01Research Grade Intetumumab
E55B0353Intetumumab (Reference antibody)
ICH5608-20mgIntetumumab Biosimilar - Research Grade
ABS-161-100ugIntetumumab Biosimilar, Research Grade
GTR18780603-01(Intetumumab) Biosimilar Reference Antibody
GTR18697881-01Intetumumab Human Monoclonal Antibody
RA0433-01Intetumumab (Biosimilar Reference Antibody) (ITGAVB3)

Popular Products